Formycon AG (0W4N.L)

EUR 53.2

(0.95%)

Long Term Debt Summary of Formycon AG

Formycon AG's latest annual long term debt in 2023 was 7.81 Million EUR , down -60.93% from previous year.
Formycon AG's latest quarterly long term debt in 2024 Q2 was - EUR , down 0.0% from previous quarter.
Formycon AG reported annual long term debt of 20 Million EUR in 2022, up 353.93% from previous year.
Formycon AG reported annual long term debt of 4.4 Million EUR in 2021, down -11.54% from previous year.
Formycon AG reported quarterly long term debt of 7.72 Million EUR for 2023 Q2, down 0.0% from previous quarter.
Formycon AG reported quarterly long term debt of 7.81 Million EUR for 2023 FY, down -60.93% from previous quarter.

Annual Long Term Debt Chart of Formycon AG (2023 - 2009)

Historical Annual Long Term Debt of Formycon AG (2023 - 2009)

Year	Long Term Debt	Long Term Debt Growth
2023	7.81 Million EUR	-60.93%
2022	20 Million EUR	353.93%
2021	4.4 Million EUR	-11.54%
2020	4.98 Million EUR	0.0%
2019	- EUR	100.0%
2018	-519.7 Thousand EUR	0.0%
2017	- EUR	0.0%
2016	- EUR	0.0%
2015	- EUR	0.0%
2014	- EUR	0.0%
2013	- EUR	0.0%
2012	- EUR	-100.0%
2011	291 Thousand EUR	0.0%
2010	- EUR	0.0%
2009	- EUR	0.0%

Year	Long Term Debt	Long Term Debt Growth
2024 Q2	- EUR	0.0%
2023 Q2	7.72 Million EUR	0.0%
2023 FY	7.81 Million EUR	-60.93%
2023 Q4	7.81 Million EUR	0.0%
2022 Q2	10 Million EUR	0.0%
2022 FY	20 Million EUR	353.93%
2022 Q4	20 Million EUR	0.0%
2021 FY	4.4 Million EUR	-11.54%
2021 Q4	4.4 Million EUR	0.0%
2021 Q2	- EUR	0.0%
2020 FY	4.98 Million EUR	0.0%
2020 Q4	- EUR	0.0%
2020 Q2	- EUR	0.0%
2019 FY	- EUR	100.0%
2019 Q4	- EUR	0.0%
2019 Q2	-519.7 Thousand EUR	0.0%
2018 FY	-519.7 Thousand EUR	0.0%
2018 Q2	1.89 Million EUR	0.0%
2018 Q4	-0.46 EUR	0.0%
2017 Q4	- EUR	0.0%
2017 FY	- EUR	0.0%
2017 Q2	- EUR	0.0%
2016 FY	- EUR	0.0%
2016 Q4	- EUR	0.0%
2016 Q2	- EUR	0.0%
2015 Q4	- EUR	0.0%
2015 FY	- EUR	0.0%
2015 Q2	- EUR	0.0%
2014 Q2	- EUR	0.0%
2014 FY	- EUR	0.0%
2014 Q4	- EUR	0.0%
2013 Q4	- EUR	0.0%
2013 FY	- EUR	0.0%
2013 Q2	- EUR	0.0%
2012 Q4	- EUR	0.0%
2012 Q2	1.57 Million EUR	0.0%
2012 FY	- EUR	-100.0%
2011 FY	291 Thousand EUR	0.0%
2010 FY	- EUR	0.0%
2009 FY	- EUR	0.0%

Peer Long Term Debt Comparison of Formycon AG

Name	Long Term Debt	Long Term Debt Difference
Boiron SA	6.64 Million EUR	-17.607%
Laboratorios Farmaceuticos Rovi, S.A.	38.57 Million EUR	79.741%
Vetoquinol SA	9.66 Million EUR	19.124%
Valneva SE	132.76 Million EUR	94.114%
AB Science S.A.	16.98 Million EUR	53.997%
Nanobiotix S.A.	41.66 Million EUR	81.241%
PHAXIAM Therapeutics S.A.	7.03 Million EUR	-11.166%
Vivoryon Therapeutics N.V.	- EUR	-Infinity%
BioSenic S.A.	15.57 Million EUR	49.817%
ABIVAX Société Anonyme	44.69 Million EUR	82.516%